2025-04-012026-03-312026-03-31false08577124ALIGN CHIROPRACTIC (NORFOLK) LIMITED2026-10-12falseiso4217:GBPxbrli:pure085771242025-03-31085771242026-03-31085771242025-04-012026-03-31085771242024-03-31085771242025-03-31085771242024-04-012025-03-3108577124bus:SmallEntities2025-04-012026-03-3108577124bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3108577124bus:FullAccounts2025-04-012026-03-3108577124bus:PrivateLimitedCompanyLtd2025-04-012026-03-3108577124core:WithinOneYear2026-03-3108577124core:AfterOneYear2026-03-3108577124core:WithinOneYear2025-03-3108577124core:AfterOneYear2025-03-3108577124core:ShareCapital2026-03-3108577124core:SharePremium2026-03-3108577124core:RevaluationReserve2026-03-3108577124core:OtherReservesSubtotal2026-03-3108577124core:RetainedEarningsAccumulatedLosses2026-03-3108577124core:ShareCapital2025-03-3108577124core:SharePremium2025-03-3108577124core:RevaluationReserve2025-03-3108577124core:OtherReservesSubtotal2025-03-3108577124core:RetainedEarningsAccumulatedLosses2025-03-3108577124core:LandBuildings2026-03-3108577124core:PlantMachinery2026-03-3108577124core:Vehicles2026-03-3108577124core:FurnitureFittings2026-03-3108577124core:OfficeEquipment2026-03-3108577124core:NetGoodwill2026-03-3108577124core:IntangibleAssetsOtherThanGoodwill2026-03-3108577124core:ListedExchangeTraded2026-03-3108577124core:UnlistedNon-exchangeTraded2026-03-3108577124core:LandBuildings2025-03-3108577124core:PlantMachinery2025-03-3108577124core:Vehicles2025-03-3108577124core:FurnitureFittings2025-03-3108577124core:OfficeEquipment2025-03-3108577124core:NetGoodwill2025-03-3108577124core:IntangibleAssetsOtherThanGoodwill2025-03-3108577124core:ListedExchangeTraded2025-03-3108577124core:UnlistedNon-exchangeTraded2025-03-3108577124core:LandBuildings2025-04-012026-03-3108577124core:PlantMachinery2025-04-012026-03-3108577124core:Vehicles2025-04-012026-03-3108577124core:FurnitureFittings2025-04-012026-03-3108577124core:OfficeEquipment2025-04-012026-03-3108577124core:NetGoodwill2025-04-012026-03-3108577124core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3108577124core:ListedExchangeTraded2025-04-012026-03-3108577124core:UnlistedNon-exchangeTraded2025-04-012026-03-3108577124core:MoreThanFiveYears2025-04-012026-03-3108577124core:Non-currentFinancialInstruments2026-03-3108577124core:Non-currentFinancialInstruments2025-03-3108577124dpl:CostSales2025-04-012026-03-3108577124dpl:DistributionCosts2025-04-012026-03-3108577124core:LandBuildings2025-04-012026-03-3108577124core:PlantMachinery2025-04-012026-03-3108577124core:Vehicles2025-04-012026-03-3108577124core:FurnitureFittings2025-04-012026-03-3108577124core:OfficeEquipment2025-04-012026-03-3108577124dpl:AdministrativeExpenses2025-04-012026-03-3108577124core:NetGoodwill2025-04-012026-03-3108577124core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3108577124dpl:GroupUndertakings2025-04-012026-03-3108577124dpl:ParticipatingInterests2025-04-012026-03-3108577124dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3108577124core:ListedExchangeTraded2025-04-012026-03-3108577124dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3108577124core:UnlistedNon-exchangeTraded2025-04-012026-03-3108577124dpl:CostSales2024-04-012025-03-3108577124dpl:DistributionCosts2024-04-012025-03-3108577124core:LandBuildings2024-04-012025-03-3108577124core:PlantMachinery2024-04-012025-03-3108577124core:Vehicles2024-04-012025-03-3108577124core:FurnitureFittings2024-04-012025-03-3108577124core:OfficeEquipment2024-04-012025-03-3108577124dpl:AdministrativeExpenses2024-04-012025-03-3108577124core:NetGoodwill2024-04-012025-03-3108577124core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3108577124dpl:GroupUndertakings2024-04-012025-03-3108577124dpl:ParticipatingInterests2024-04-012025-03-3108577124dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3108577124core:ListedExchangeTraded2024-04-012025-03-3108577124dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3108577124core:UnlistedNon-exchangeTraded2024-04-012025-03-3108577124core:NetGoodwill2026-03-3108577124core:IntangibleAssetsOtherThanGoodwill2026-03-3108577124core:LandBuildings2026-03-3108577124core:PlantMachinery2026-03-3108577124core:Vehicles2026-03-3108577124core:FurnitureFittings2026-03-3108577124core:OfficeEquipment2026-03-3108577124core:AfterOneYear2026-03-3108577124core:WithinOneYear2026-03-3108577124core:ListedExchangeTraded2026-03-3108577124core:UnlistedNon-exchangeTraded2026-03-3108577124core:ShareCapital2026-03-3108577124core:SharePremium2026-03-3108577124core:RevaluationReserve2026-03-3108577124core:OtherReservesSubtotal2026-03-3108577124core:RetainedEarningsAccumulatedLosses2026-03-3108577124core:NetGoodwill2025-03-3108577124core:IntangibleAssetsOtherThanGoodwill2025-03-3108577124core:LandBuildings2025-03-3108577124core:PlantMachinery2025-03-3108577124core:Vehicles2025-03-3108577124core:FurnitureFittings2025-03-3108577124core:OfficeEquipment2025-03-3108577124core:AfterOneYear2025-03-3108577124core:WithinOneYear2025-03-3108577124core:ListedExchangeTraded2025-03-3108577124core:UnlistedNon-exchangeTraded2025-03-3108577124core:ShareCapital2025-03-3108577124core:SharePremium2025-03-3108577124core:RevaluationReserve2025-03-3108577124core:OtherReservesSubtotal2025-03-3108577124core:RetainedEarningsAccumulatedLosses2025-03-3108577124core:NetGoodwill2024-03-3108577124core:IntangibleAssetsOtherThanGoodwill2024-03-3108577124core:LandBuildings2024-03-3108577124core:PlantMachinery2024-03-3108577124core:Vehicles2024-03-3108577124core:FurnitureFittings2024-03-3108577124core:OfficeEquipment2024-03-3108577124core:AfterOneYear2024-03-3108577124core:WithinOneYear2024-03-3108577124core:ListedExchangeTraded2024-03-3108577124core:UnlistedNon-exchangeTraded2024-03-3108577124core:ShareCapital2024-03-3108577124core:SharePremium2024-03-3108577124core:RevaluationReserve2024-03-3108577124core:OtherReservesSubtotal2024-03-3108577124core:RetainedEarningsAccumulatedLosses2024-03-3108577124core:AfterOneYear2025-04-012026-03-3108577124core:WithinOneYear2025-04-012026-03-3108577124core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3108577124core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3108577124core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3108577124core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3108577124core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3108577124core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3108577124core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3108577124core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3108577124core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3108577124core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3108577124core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3108577124core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3108577124core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3108577124core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3108577124core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3108577124core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3108577124core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3108577124core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3108577124core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3108577124core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3108577124core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3108577124core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3108577124core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3108577124core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3108577124core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3108577124core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3108577124core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3108577124bus:Director12025-04-012026-03-3108577124bus:Director22025-04-012026-03-31

ALIGN CHIROPRACTIC (NORFOLK) LIMITED

Registered Number
08577124
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

ALIGN CHIROPRACTIC (NORFOLK) LIMITED
Company Information
for the year from 1 April 2025 to 31 March 2026

Directors

WHITE, Lara Taisjia May, Dr
WHITE, Stefan Michael

Company Secretary

WHITE, Stefan

Registered Address

No1 Beech Rise Business Park Beech Avenue
Taverham
Norwich
NR8 6HW

Registered Number

08577124 (England and Wales)
ALIGN CHIROPRACTIC (NORFOLK) LIMITED
Balance Sheet as at
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Intangible assets311
Tangible assets425,42130,903
25,42230,904
Current assets
Debtors42,35434,962
Cash at bank and on hand7,7919,817
50,14544,779
Creditors amounts falling due within one year5(37,238)(34,953)
Net current assets (liabilities)12,9079,826
Total assets less current liabilities38,32940,730
Creditors amounts falling due after one year6(30,307)(37,954)
Net assets8,0222,776
Capital and reserves
Called up share capital100100
Profit and loss account7,9222,676
Shareholders' funds8,0222,776
The financial statements were approved and authorised for issue by the Board of Directors on 12 October 2026, and are signed on its behalf by:
WHITE, Lara Taisjia May, Dr
Director
Registered Company No. 08577124
ALIGN CHIROPRACTIC (NORFOLK) LIMITED
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Intangible assets
Goodwill is amortised over 10 years.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Vehicles25
Office Equipment25
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
2.Average number of employees

20262025
Average number of employees during the year33
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 April 2530,00030,000
At 31 March 2630,00030,000
Amortisation and impairment
At 01 April 2529,99929,999
At 31 March 2629,99929,999
Net book value
At 31 March 2611
At 31 March 2511
4.Tangible fixed assets

Plant & machinery

Vehicles

Total

£££
Cost or valuation
At 01 April 2526,44746,09072,537
Additions2,993-2,993
At 31 March 2629,44046,09075,530
Depreciation and impairment
At 01 April 2521,46920,16541,634
Charge for year1,9946,4818,475
At 31 March 2623,46326,64650,109
Net book value
At 31 March 265,97719,44425,421
At 31 March 254,97825,92530,903
5.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables14
Bank borrowings and overdrafts7,4537,453
Taxation and social security24,72922,441
Finance lease and HP contracts4,9654,965
Other creditors9090
Total37,23834,953
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
6.Creditors: amounts due after one year

2026

2025

££
Bank borrowings and overdrafts30,30737,954
Total30,30737,954
7.Related party transactions
At the year end Mr and Mrs White owed the company £29,415 (2025: £29,540). Interest was charged by the company to Mr & Mrs White.